Keyword: Abbott Laboratories
Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,
Abbott plans to launch a head-to-head study that puts its structural heart device up against a newer generation of blood thinners.
Abbott received a CE mark for a first-of-its-kind transcatheter mitral valve implantation system.
Not long after elevating a company veteran to be its next CEO, Abbott has now done the same within its financial leadership.
The FDA approved a less invasive surgical technique for the placement of Abbott’s best-selling heart pump, allowing patients to avoid open surgery.
A new connector to prevent hospital errors has been introduced in the niche feeding tube industry, but critics say the device creates new risks.
Abbott CEO White set to step down after 21 years; Lonza head Funk out after just a year; Progenics' Baker could be out after board shuffle.
The FDA recently labeled two device recalls as Class I, the most serious, after they were launched by Philips and Abbott earlier this year.
Abbott teamed up with Omada Health to offer its FreeStyle Libre CGM system through the latter’s digital care program for type 2 diabetes.
After ponying up more than $800 million on its deal with Reata Pharmaceuticals, AbbVie is calling it quits.